Hanmi’s Amosartan wins bronze medal
Published: 2009-12-18 06:58:00
Updated: 2009-12-18 06:58:00
The Ministry of Knowledge Economy awarded on December 15 a bronze medal to Hanmi Pharm Co., honoring for its technological achievement in the development of Amosartan, a combination drug of amodipine and losartan potassium.
"This award will give us momentum to continue our quest to become a le...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.